Patents Assigned to Encore Medical Asset Corporation
  • Patent number: 11541226
    Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: January 3, 2023
    Assignee: Encore Medical Asset Corporation
    Inventors: Jon E. Beck, Robert F. Hause, Jr.
  • Patent number: 10478610
    Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: November 19, 2019
    Assignee: Encore Medical Asset Corporation
    Inventors: Jon E. Beck, Robert F. Hause, Jr.
  • Patent number: 9808619
    Abstract: Electrotherapy systems and methods for delivering an electrostimulation treatment program to a user while reducing the risk of inducing cardiac fibrillation. The systems and methods detect electrostimulation treatment program delivery characteristics, including a pulse intensity above a preset limit; a pulse duration above a preset limit; an inappropriately compensated pulse; a charge per pulse above a predetermined limit; a current improperly exiting from a stimulation channel; a current present outside of a pulse; an excitation pulse and a compensation pulse generated on different channels; an inter-pulse time less than a predetermined limit; and a time between an excitation and a compensation pulse greater than a predetermined limit. The limits are selected in relation to an objective of reducing the risk of inducing cardiac fibrillation.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: November 7, 2017
    Assignee: Encore Medical Asset Corporation
    Inventors: Felix Buhlmann, Etienne Dunant, Steve Guex, David Truffer, Pierre-Yves Mueller
  • Patent number: 9757553
    Abstract: An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: September 12, 2017
    Assignee: Encore Medical Asset Corporation
    Inventors: Ralph Koschinsky, James D. Isaacson, Robert F. Hause
  • Patent number: 9669211
    Abstract: A method and apparatus for applying neuromuscular electrical stimulation to an agonist/antagonist muscle pair to move a limb about a joint includes generating a first pattern of neuromuscular electrical stimulation pulses for output through a first channel to a first pair of electrodes and generating a second pattern of neuromuscular stimulation pulses for output through a second channel to a second pair of electrodes. The first pair of electrodes are attached to the agonist muscle of the agonist/antagonist muscle pair, and the second pair of electrodes are attached to the antagonist muscle. A first pattern of electrical stimulation pulses is transmitted through the first pair of electrodes to the agonist muscle at a first intensity level to initiate contraction of the agonist muscle, and then at a second intensity level which is less than the first intensity level to continue contraction of the agonist muscle.
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: June 6, 2017
    Assignee: Encore Medical Asset Corporation
    Inventors: Yorick Wijting, Jeffrey K. Pohl
  • Patent number: 9468757
    Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: October 18, 2016
    Assignee: Encore Medical Asset Corporation
    Inventors: Jon E. Beck, Robert F. Hause, Jr.
  • Patent number: 9352151
    Abstract: A method and apparatus for applying neuromuscular electrical stimulation to an agonist/antagonist muscle pair to move a limb about a joint includes generating a first pattern of neuromuscular electrical stimulation pulses for output through a first channel to a first pair of electrodes and generating a second pattern of neuromuscular stimulation pulses for output through a second channel to a second pair of electrodes. The first pair of electrodes are attached to the agonist muscle of the agonist/antagonist muscle pair, and the second pair of electrodes are attached to the antagonist muscle. A first pattern of electrical stimulation pulses is transmitted through the first pair of electrodes to the agonist muscle at a first intensity level to initiate contraction of the agonist muscle, and then at a second intensity level which is less than the first intensity level to continue contraction of the agonist muscle.
    Type: Grant
    Filed: December 30, 2013
    Date of Patent: May 31, 2016
    Assignee: Encore Medical Asset Corporation
    Inventors: Yorick Wijting, Jeffrey K. Pohl
  • Patent number: 9180286
    Abstract: An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.
    Type: Grant
    Filed: May 1, 2013
    Date of Patent: November 10, 2015
    Assignee: Encore Medical Asset Corporation
    Inventors: Ralph Koschinsky, James D. Isaacson, Robert F. Hause
  • Patent number: 9084879
    Abstract: An iontophoretic drug delivery device storage apparatus and a method of using that device is disclosed. The device comprises a fluid reservoir, an electrode assembly and a tray apparatus. The fluid reservoir is capable of retaining a medicament and has a sealed fluid chamber defined by at least one seal. The seal includes a weaker region and a pinch-like configuration associated with that region such that application of pressure to the fluid reservoir breaks the weaker region of the seal, releasing the retained medicament. The electrode assembly comprises an active electrode, at least two passive electrodes a medicament carrying region, and a moat region around the medicament carrying region so that once fluid is delivered from the fluid reservoir to the electrode assembly the fluid is substantially retained in the medicament carrying means.
    Type: Grant
    Filed: October 25, 2006
    Date of Patent: July 21, 2015
    Assignee: Encore Medical Asset Corporation
    Inventors: Gregory A. Fischer, Malcolm E. Taylor, Edward M. Kolvek
  • Publication number: 20140288482
    Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.
    Type: Application
    Filed: June 3, 2014
    Publication date: September 25, 2014
    Applicant: Encore Medical Asset Corporation
    Inventors: Jon E. Beck, Robert F. Hause, JR.
  • Patent number: 8819879
    Abstract: A therapeutic treatment table comprises a frame and a treatment platform that is mounted on the frame and adapted to support at least a portion of the body of a patient. A preferred treatment table also includes an arm support section which is mounted on the frame. The arm support section comprises an arm support that is moveable by a patient on the table independently of the treatment platform.
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: September 2, 2014
    Assignee: Encore Medical Asset Corporation
    Inventors: Greg Day, Ken Bolam, Jeff Powe, Rainer Teufel
  • Patent number: 8788031
    Abstract: An iontophoretic drug delivery device storage apparatus and a method of using that device is disclosed. The device comprises a fluid reservoir, an electrode assembly and a tray apparatus. The fluid reservoir is capable of retaining a medicament and has a sealed fluid chamber defined by at least one seal. The seal includes a weaker region and a pinch-like configuration associated with that region such that application of pressure to the fluid reservoir breaks the weaker region of the seal, releasing the retained medicament. The electrode assembly comprises an active electrode, at least two passive electrodes a medicament carrying region, and a moat region around the medicament carrying region so that once fluid is delivered from the fluid reservoir to the electrode assembly the fluid is substantially retained in the medicament carrying means.
    Type: Grant
    Filed: October 25, 2006
    Date of Patent: July 22, 2014
    Assignee: Encore Medical Asset Corporation
    Inventors: Gregory A. Fischer, Malcolm E. Taylor, Edward M. Kolvek
  • Patent number: 8781572
    Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.
    Type: Grant
    Filed: February 14, 2013
    Date of Patent: July 15, 2014
    Assignee: Encore Medical Asset Corporation
    Inventors: Robert F. Hause, Jr., Jon E. Beck
  • Publication number: 20140188013
    Abstract: A method and apparatus for applying neuromuscular electrical stimulation to an agonist/antagonist muscle pair to move a limb about a joint includes generating a first pattern of neuromuscular electrical stimulation pulses for output through a first channel to a first pair of electrodes and generating a second pattern of neuromuscular stimulation pulses for output through a second channel to a second pair of electrodes. The first pair of electrodes are attached to the agonist muscle of the agonist/antagonist muscle pair, and the second pair of electrodes are attached to the antagonist muscle. A first pattern of electrical stimulation pulses is transmitted through the first pair of electrodes to the agonist muscle at a first intensity level to initiate contraction of the agonist muscle, and then at a second intensity level which is less than the first intensity level to continue contraction of the agonist muscle.
    Type: Application
    Filed: December 30, 2013
    Publication date: July 3, 2014
    Applicant: Encore Medical Asset Corporation
    Inventors: Yorick Wijting, Jeffrey K. Pohl
  • Publication number: 20140039376
    Abstract: An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.
    Type: Application
    Filed: May 1, 2013
    Publication date: February 6, 2014
    Applicant: ENCORE MEDICAL ASSET CORPORATION
    Inventor: ENCORE MEDICAL ASSET CORPORATION
  • Patent number: 8620438
    Abstract: A method and apparatus for applying neuromuscular electrical stimulation to an agonist/antagonist muscle pair to move a limb about a joint includes generating a first pattern of neuromuscular electrical stimulation pulses for output through a first channel to a first pair of electrodes and generating a second pattern of neuromuscular stimulation pulses for output through a second channel to a second pair of electrodes. The first pair of electrodes are attached to the agonist muscle of the agonist/antagonist muscle pair, and the second pair of electrodes are attached to the antagonist muscle. A first pattern of electrical stimulation pulses is transmitted through the first pair of electrodes to the agonist muscle at a first intensity level to initiate contraction of the agonist muscle, and then at a second intensity level which is less than the first intensity level to continue contraction of the agonist muscle.
    Type: Grant
    Filed: February 13, 2007
    Date of Patent: December 31, 2013
    Assignee: Encore Medical Asset Corporation
    Inventors: Yorick Wijting, Jeffrey K. Pohl
  • Publication number: 20130226135
    Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.
    Type: Application
    Filed: February 14, 2013
    Publication date: August 29, 2013
    Applicant: ENCORE MEDICAL ASSET CORPORATION
    Inventor: ENCORE MEDICAL ASSET CORPORATION
  • Patent number: 8447393
    Abstract: An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.
    Type: Grant
    Filed: August 5, 2011
    Date of Patent: May 21, 2013
    Assignee: Encore Medical Asset Corporation
    Inventors: Ralph Koschinsky, Jim Isaacson, Robert F. Hause
  • Patent number: 8386029
    Abstract: The present invention is directed to a method and apparatus for an electrotherapeutic system including a first and second electrode. Each electrode includes a respective resistance wherein during operation of the electrotherapeutic system, an electrochemical reaction involving one or both of the electrodes varies the respective resistance of at least one of the electrodes.
    Type: Grant
    Filed: March 31, 2005
    Date of Patent: February 26, 2013
    Assignee: Encore Medical Asset Corporation
    Inventors: Robert F. Hause, Jr., Jon E. Beck
  • Patent number: 8214030
    Abstract: An iontophoresis apparatus and method is disclosed that is suited to deliver a plurality of treatment methods such as, but not limited to, body site conductivity enhancement followed by low voltage iontophoresis.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: July 3, 2012
    Assignee: Encore Medical Asset Corporation
    Inventors: Robert F. Hause, Jr., Jon E. Beck